[Skip to Navigation]
January 1999

Acute Generalized Exanthematous Pustulosis Induced by Metronidazole: The Role of Patch Testing

Author Affiliations

Not Available

Arch Dermatol. 1999;135(1):93-94. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-1-dlt0199

The challenge of cutaneous adverse drug reactions for the consultant dermatologist is in determining a specific etiologic agent, especially in the setting of polypharmacy. The risk of reexposure to individual medications usually outweighs the benefits, especially in the case of severe drug eruptions. Recently, patch testing has been advocated as a potentially useful test in some severe cutaneous adverse drug reactions, especially acute generalized exanthematous pustulosis (AGEP).1